Remember the “TRL” studio and crowds in Times Square? Music? Carson Daly? MTV hopes you do, and will tune in again.
NYS Entity Status
NYS Filing Date
AUGUST 18, 2014
NYS DOS ID#
NYS Entity Type
FOREIGN BUSINESS CORPORATION
2014 - FACTOR SUPPORT NETWORK PHARMACY, INC.
Around the Web
- MTV Mines the Past for Its Future: ‘Total Request Live’
By JOHN KOBLIN - Sunday Jul 30, 2017
- PeopleTV Strikes Deal With Twitter for Streaming Video
Monday Nov 6, 2017
Time Inc.’s ad-supported, online video network PeopleTV has announced a deal with Twitter to provide streaming content and live programming for the social-media platform.
- CVS reportedly offers over $66B to acquire Aetna
By Reuters - Friday Oct 27, 2017
U.S. pharmacy operator CVS Health Corp has made an offer to acquire No. 3 U.S. health insurer Aetna Inc for more than $200 per share, or over $66 billion, people familiar with the matter said on Thursday. A deal would merge one of the nation’s largest pharmacy benefits managers and pharmacy operators with one of...
- Abbvie’s hep C drug pricing threatens Gilead’s dominance
By Max Nisen - Tuesday Aug 8, 2017
Pharma already leads the business world in unpredictability, with billions in sales potentially riding on a few points of statistical significance in a clinical trial.[...] even within that context, a series of blockbuster medicines for hepatitis C have made for a roller-coaster ride for companies and investors.AbbVie Inc. last week threw another big curve at this market by pricing its newly FDA-approved drug Mavyret — which might be the most effective hepatitis C medicine approved yet — at a massive discount.Medicines from Johnson & Johnson, Merck & Co. Inc. and Vertex Pharmaceuticals Inc. approved within the past six years, which once booked billions in combined sales, are now essentially non-factors.After offering behind-the-scene discounts to insurance companies, pharmacy benefit managers and other payers, Mavyret’s price is actually not far from Harvoni’s, according to Bloomberg Intelligence.The real headache for Gilead — which already faces steep declines in hepatitis C drug sales because of increasing competition and the fact that many patients have been cured — lies in the fact that not all hepatitis patients or medicines are the same.AbbVie’s new drug can treat all of the major subtypes of hepatitis C. And it can cure the disease in many patients in just eight weeks.
- Discovery to Buy Scripps, Owner of Food Network, in $11.9 Billion Deal
By EMILY STEEL - Monday Jul 31, 2017
The agreement would add to consolidation in the telecommunications and media industries, as TV companies seek to better compete with cable and broadband providers.
- Verizon to Compete With AT&T for Public-Safety Customers
Wednesday Aug 16, 2017
Verizon Communications Inc. said it is building dedicated lanes at the core of its U.S. network for firefighters and other first responders, a bid to compete with AT&T Inc.’s plans for its own public-safety network.